US Tariffs on Korean Cosmetics in 2026: What the 15% Reciprocal Rate, KORUS, and the End of De Minimis Mean for Indie K-Beauty Brand Cost Math
By the ALTA MEET editorial team | K-beauty ODM consulting
Eighteen months ago, an indie K-beauty founder could land a 3,000-unit pallet of serum from a Seoul ODM at Los Angeles, clear customs, and pay zero duty. Cosmetic preparations under HTS 3304 sat at a 0% Column 1 rate. Direct-to-consumer parcels under $800 cleared duty-free under the de minimis rule. Both of those structural advantages are gone in 2026.
Korean cosmetic shipments to the US now carry a 15% reciprocal tariff. The de minimis exemption ended August 29, 2025. The November 2025 US-Korea Strategic Trade and Investment Deal locked in the 15% cap, with a narrow list of exempted categories that does not include skincare or color cosmetics. KORUS Free Trade Agreement preference still exists, but for most cosmetic HTS lines it does not produce a meaningfully lower rate than 15%.
For indie founders who built unit economics on a duty-free landing cost, this is a structural reset. A 1,000-unit serum order at USD 4.20 unit cost FOB Seoul now lands at the US port with USD 0.63 of new duty per unit before freight, insurance, and warehousing. At 3,000 units that is USD 1,890 of duty that did not exist in 2024. For a brand pulling 35% gross margin on a USD 32 retail price, the tariff alone consumes ~2 points of margin if absorbed, or 2% of retail if passed on at checkout.
This guide walks through what actually changed, what the cost math looks like at indie scale, and what to renegotiate with your Korean ODM right now. It is written for indie K-beauty founders manufacturing through Korean ODMs at 1,000 to 10,000 MOQ.
The Tariff Reality Indie Brands Face in 2026
Three things shifted between summer 2025 and the end of 2025.
First, the Trump administration imposed reciprocal tariffs on most US trading partners under the IEEPA framework. South Korea's reciprocal rate landed at 15% after a brief period at higher provisional rates. Cosmetics, classified under HTS 3304 (beauty and skin care preparations) and HTS 3401 (soaps, organic surface-active products), now carry that 15% additional duty on top of the existing Column 1 MFN rate. Because most HTS 3304 lines sit at 0% MFN, the practical effective rate on Korean cosmetic imports is 15%.
Second, the de minimis exemption that allowed shipments valued under USD 800 to enter the US duty-free was eliminated on August 29, 2025. Direct-to-consumer parcels from Korean cosmetic sellers, which had used this channel to ship to US consumers without paying duty or filing formal customs entries, now face either the country-of-origin tariff rate or fixed processing fees in the USD 80 to USD 200 range (the fixed-fee option is available only for a six-month transition window).
Third, the November 13, 2025 US-Korea Strategic Trade and Investment Deal locked in the 15% reciprocal cap. The deal also created the Potential Tariff Adjustments for Aligned Partners (PTAAP) list, which exempts certain Korean exports including generic pharmaceuticals, their ingredients, certain chemical precursors, and natural resources not available domestically. Cosmetic finished goods are not on the PTAAP list. Auto and parts tariffs were reduced to 15% retroactive to November 1, 2025; the rest of the goods schedule took effect November 14, 2025.
For an indie K-beauty brand, the practical translation is straightforward. A serum, cream, sunscreen (cosmetic-classified, not OTC drug), cleanser, or color cosmetic manufactured in Korea and shipped to the US now carries a 15% effective duty rate at the port of entry. The only way around that 15% is if the specific HTS line you import under qualifies for a reduced or zero rate under KORUS FTA, and even then the Column 1 MFN rate for most HTS 3304 subheadings is already 0% which means the 15% reciprocal still applies on top.
What Changed in 2025: De Minimis, Reciprocal Tariff, KORUS Reset
The de minimis ending matters even for founders who only sell wholesale or through US retailers. Here is why. Many indie K-beauty brands have used a hybrid model: a US warehouse for wholesale and Amazon fulfillment, and direct-from-Korea drop-shipping for low-volume online orders. The drop-ship leg used de minimis to bypass tariff and customs entry on individual customer parcels. That leg is now economically unworkable for cosmetic categories where the parcel value sits between USD 30 and USD 800.
The reciprocal tariff is structurally different from the Section 301 China tariffs that dominated 2018-2024 trade discussion. Those tariffs targeted specific HTS lines and gave Korean ODMs a competitive cost advantage over Chinese OEMs on lines where China carried 25% Section 301 plus Section 232 plus other duties. The 2025 reciprocal tariff is country-level, not product-level. It applies to virtually every Korean export above the small PTAAP exempted list. A Korean serum and a Chinese serum now both carry country-level reciprocal duty, but at different rates (China's reciprocal rate has been the subject of ongoing bilateral negotiation; Korea's is fixed at 15% under the November 2025 deal).
The KORUS FTA reset is the most misunderstood piece. KORUS is still active. Goods that meet KORUS originating rules of origin still qualify for KORUS preferential treatment. But the November 2025 deal specified that the United States will apply the higher of (a) the KORUS or MFN rate, or (b) a tariff rate of 15% on originating goods from South Korea under reciprocal tariff provisions. For HTS 3304 lines that sat at 0% under both MFN and KORUS, the higher rate is now 15%. KORUS preference does not save you on cosmetic finished goods. It still saves you on certain ingredient and packaging inputs, which matters for components shipped from Korea into US-based contract finishers, but for the standard "manufacture in Korea, import finished cosmetic to US" model the 15% is unavoidable.
How the 15% Reciprocal Tariff Actually Lands on a K-Beauty Cosmetic Shipment
The mechanics matter because indie founders often confuse "tariff on FOB price" with "tariff on landed cost" or "tariff on retail price."
US tariffs are assessed on the dutiable value of the imported goods, which under WTO valuation rules is typically the transaction value: what the importer of record paid to the exporter, adjusted for certain inclusions like assists, royalties, and certain selling commissions. For an indie brand importing a finished serum from a Korean ODM at USD 4.20 per unit FOB Incheon, the dutiable value per unit is USD 4.20 (approximately, with adjustments). The 15% reciprocal tariff applies to that value.
A 3,000-unit shipment at USD 4.20 FOB carries:
Dutiable value: USD 12,600
15% reciprocal duty: USD 1,890
Merchandise Processing Fee (MPF, 0.3464% of dutiable value, min ~USD 32, max ~USD 634 in 2026): USD 43.65
Harbor Maintenance Fee (HMF, 0.125% if shipping by ocean): USD 15.75
Total US import duty and fees per shipment: ~USD 1,949
Per-unit cost impact: ~USD 0.65
That USD 0.65 sits between the FOB cost and the warehouse cost. Ocean freight (Korea-to-Long Beach FCL or LCL share), insurance, drayage, and US warehousing layer on top. Most indie founders we work with see a landed-to-warehouse cost increase of 18% to 22% versus the 2024 baseline, with the 15% tariff being the dominant new line and MPF/HMF being old line items that simply got more visible because they sit next to the new tariff entry on the broker invoice.
The impact on retail price depends on absorption strategy. Three patterns dominate at indie scale:
Full absorption (brand eats the cost). Margin compresses 2 to 4 points depending on retail price. Sustainable only on lines with 60%+ gross margin to start.
Pass-through (raise retail price). USD 32 SKU becomes USD 36 to USD 38 to preserve the same dollar margin. Risk: consumer price sensitivity, especially in subscription and Amazon channels.
Hybrid (split between brand and consumer). Most common at indie scale. Raise price USD 2 to USD 3, absorb the remainder.
The Indie Founder Cost Math: A Pre-Tariff vs Post-Tariff Walkthrough
Take a representative indie K-beauty serum at 1,000-unit MOQ, manufactured at a mid-tier Seoul ODM, shipped to a US 3PL in California.
Line item2024 baseline2026 post-tariffChangeFOB Incheon unit cost (formula + packaging + ODM labor)USD 4.20USD 4.200%Ocean freight LCL share (per unit)USD 0.42USD 0.47+12% (carrier surcharges)US reciprocal tariff (15%)USD 0.00USD 0.63New lineMPF + HMFUSD 0.04USD 0.04flatCustoms broker + drayage (per unit)USD 0.18USD 0.20+11%InsuranceUSD 0.05USD 0.05flatLanded cost at California 3PLUSD 4.89USD 5.59+14.3%3PL receiving + storage (3-month average)USD 0.35USD 0.38+9%Cost in inventoryUSD 5.24USD 5.97+13.9%Retail MSRPUSD 32.00USD 32.00 (or raise to USD 36)variesGross margin at USD 32 retail83.6%81.3%-2.3 pointsGross margin if raised to USD 36 retailn/a83.4%maintained
The point of laying this out is not to push founders toward one absorption strategy or another. It is to show that at indie scale the per-unit dollar impact is modest, the gross margin impact is real but recoverable through a USD 2 to USD 4 retail adjustment, and the planning work is mostly about cash flow timing and SKU prioritization.
The bigger cost-math risk for indie brands is not the 15% itself. It is the working capital impact on first-order economics. A 1,000-unit launch SKU that used to require ~USD 4,890 in landed cash before any US logistics now requires ~USD 5,590. A four-SKU launch collection moves from ~USD 19,500 to ~USD 22,400 in pre-launch landed inventory cash. That gap is the difference between "raise from friends and family" and "raise a small angel round" for some founders.
A Note From Liz, Founder, ALTA MEET
I'm Liz, I run altameet from Manhattan, NYC, and we sit on the Korea side of about a hundred indie K-beauty brand decisions every month. The tariff change hit us harder than most of our clients realized, because the founders saw it as "a 15% cost line I have to absorb or pass through" and our ODM partners saw it as "a new reason for indie brands to delay confirming purchase orders." The result has been a quiet 3 to 6 week slowdown across the Seoul side of the indie K-beauty pipeline as both sides reset expectations. If you are mid-flight on a Korean ODM project right now and want a quick gut-check on which line items in your quote are actually movable in this environment, grab 15 minutes free with me.
Three Strategic Responses Indie Brands Are Taking
Across the indie K-beauty brands we have worked with through the November 2025 to May 2026 window, three response patterns dominate.
The first is selective US repackaging. The brand manufactures the bulk formula in Korea, ships the bulk in larger containers (which sometimes carry a slightly different HTS classification under bulk personal care preparations), and contracts a US-based packaging finisher to fill, label, and case-pack the finished SKU. This shifts the import event from finished cosmetic to bulk personal care preparation and can in some cases land a lower effective duty depending on the HTS subheading and whether KORUS preference is claimable on the bulk line. It also introduces a US-based labor cost (USD 0.30 to USD 0.80 per unit at indie volumes) and adds 2 to 3 weeks to lead time. Net impact varies; in our experience it is a wash for brands at 1,000-unit MOQ and a modest savings for brands at 10,000+ unit volumes.
The second is dual-sourcing. The brand keeps the hero SKU (the formulation that defines the brand DNA, usually a serum or essence) in Korea where the formulation IP and the manufacturer relationship are sticky, and shifts secondary SKUs (cleansers, sheet masks, simple lotions) to lower-tariff origins or US contract manufacturers. The math here is more about volume diversification than about each individual SKU's economics. Korean ODMs we partner with see this as a permanent shift, not a cyclical one.
The third is price-and-margin discipline. The brand raises retail prices 8% to 12% across the line, absorbs the rest, and tightens promotional discounting so that the effective tariff cost is not crowding out marketing budget. This is the most common response at brands with strong existing direct-to-consumer demand and pricing power. It is the worst response for brands fighting for shelf space at US retailers like Ulta or Sephora, where retail price elasticity is real and a 12% MSRP increase can materially affect velocity.
What to Renegotiate With Your Korean ODM Right Now
The 15% tariff is not negotiable. But several line items in a Korean ODM quote are.
ODM unit cost. Korean ODMs are highly aware that their indie US clients are absorbing a structural cost increase. Many are willing to share that pressure, particularly on second and third production runs where unit economics improve. Ask for a 3% to 5% unit cost reduction on commit-volume terms (e.g., 10,000 units committed across 18 months). Not every ODM will agree, but the conversation is harder to have if you do not ask explicitly.
Packaging cost lines. Korean ODMs typically quote packaging as a pass-through cost. Glass dropper bottles from Lumson Korea or Yonwoo, airless pumps from Pum-Tech, cartons from any of the dozen Seoul carton printers, individual unit labels are often the largest non-formula line items. Ask the ODM for two parallel packaging quotes (Korea-sourced and Korea-sourced but routed through a US fulfillment that handles the labeling step in the US). The labeling-in-US route can in some cases bypass a portion of the dutiable value attributable to labeled finished goods, depending on how the import is structured. Talk to your customs broker about the structure before committing.
Lead time and payment terms. The tariff effect on cash flow is the bigger near-term problem than the tariff itself. Ask the ODM for 30 to 60 day net payment terms instead of 50/50 (50% PO, 50% pre-shipment), or for milestone-based payments tied to QC sign-off rather than calendar dates. Korean ODMs are generally less flexible on payment terms than Chinese OEMs, but they have moved 3 to 5 percentage points in the last six months in our observation.
FOB versus DDP terms. Most Korean ODM contracts are FOB Incheon, with the brand acting as importer of record and paying duty directly to US Customs. A handful of larger Korean ODMs now offer DDP (Delivered Duty Paid) terms where the ODM acts as importer of record through a US subsidiary and bills the brand a combined unit-plus-duty price. The economics are usually neutral to slightly favorable for the brand, but the structural advantage is cash flow timing: the duty payment happens at the ODM's pace, not at the customs broker's invoice cycle.
Quality control and stability extras. Korean ODMs include some QC and stability testing (ISO 22716 GMP procedural baseline, ISO 17516:2014 microbiological limits, ICH Q1A(R2) stability program where applicable) in their base quote, but many indie brands pay for additional stability testing, accelerated stability, photostability (ICH Q1B), or third-party testing as added line items. These line items are negotiable and in many cases overlap with what the base QC program already covers. Ask for a line-by-line review.
Risks Indie Founders Underestimate
Five risks consistently surprise indie founders in the post-tariff environment.
Tariff classification disputes. US Customs and Border Protection (CBP) can dispute the HTS classification on entry. A serum classified as 3304.99 (Other) might be reclassified as 3304.10 (Lip make-up preparations) or another subheading depending on ingredient labeling. Most disputes do not affect the 15% reciprocal rate, but they can affect the underlying MFN rate and trigger requests for binding rulings. Ask your customs broker to file a binding ruling request before high-volume imports.
Origin certification under KORUS. Even though KORUS preference does not save money on the cosmetic finished good 15% reciprocal rate, KORUS certification still matters for ingredient imports and for the supply chain audit trail. Korean ODMs sometimes use Chinese-origin ingredient inputs (raw HA, certain peptides, certain colorants). If the finished good cannot certify Korean origin under KORUS substantial transformation rules, the import may face a different country-of-origin treatment. Ask the ODM to certify the country of origin under KORUS substantial transformation rules in writing.
MoCRA compliance overlap. The Modernization of Cosmetics Regulation Act (MoCRA) of 2022 introduced facility registration, product listing, adverse event reporting, and labeling requirements that took staged effect through 2024 and 2025. Tariff filing and MoCRA filing are separate but adjacent. Importers who get their MoCRA Responsible Person registration wrong sometimes face entry delays that compound the cash flow problem the tariff already created. Confirm your MoCRA Responsible Person, facility registration, and product listings before the first post-tariff shipment (our FDA Korean skincare import guide walks through the exact filings).
De minimis loophole closure on returns. Returns and exchange shipments from US consumers back to Korea, or vice versa, used to ride the de minimis exemption. Returns logistics now face the same duty treatment as outbound. Most indie brands have not updated their returns policy and accounting to reflect this; some are absorbing the cost without realizing it.
Section 301 cross-application. Although Korean cosmetics are not Section 301 (China) targets, Korean cosmetics that contain Chinese-origin ingredient inputs at material thresholds can in some cases trigger Section 301 review. This is a low-probability risk at indie volumes but a known compliance issue at higher volumes.
The Action Checklist for Indie K-Beauty Founders in 2026
The cost-math reset is real, but the action list is finite. For founders with a Korean ODM relationship already in motion:
Re-quote the active SKU at current terms. Ask the ODM for an updated FOB quote, an updated DDP quote if available, and an updated 12-month commit-volume quote with target unit cost.
Re-model landed cost. Use the worked example above as a template. Plug in your actual FOB unit cost, MOQ, freight quote, and 3PL cost. Identify your true 2026 landed cost per unit. Our Korean skincare manufacturing cost guide provides a baseline cost stack for serums, creams, and cleansers at indie volumes.
Re-set MSRP and absorption strategy. Decide explicitly: full absorb, pass through, hybrid. Document the decision and update marketing copy if you are repositioning price.
Reconfirm MoCRA Responsible Person registration and product listing. Make sure the cosmetic facility, the brand listing, and the adverse event reporting setup are all current. Tariff entry delays compound MoCRA filing delays.
Get a binding ruling on HTS classification. For your highest-volume SKU, file a Customs binding ruling request through your broker. Cost is modest, certainty is meaningful.
Review payment terms and cash flow. Map the new pre-launch landed inventory cash requirement. Adjust the launch sequence (one SKU at a time vs full collection at once) if the working capital gap is larger than the runway.
Audit the de minimis exposure on direct-from-Korea sales. If you have been drop-shipping any portion of US orders direct from Seoul, that channel is now economically broken. Migrate to US-warehouse fulfillment.
For founders pre-commitment, the same list applies in reverse order: confirm MoCRA registration first, then build the landed cost model, then quote the ODM, then pick the launch sequence.
Reviewed for accuracy by ALTA MEET's K-beauty manufacturing consulting team. We work hands-on with Korean ODMs on cross-border negotiations, MoCRA-aligned facility selection, and the cost structure side of indie K-beauty brand launches.
Key Takeaways
The 15% reciprocal tariff on Korean goods is structural through at least the term of the November 2025 US-Korea Strategic Trade and Investment Deal; cosmetic finished goods are not on the PTAAP exemption list.
The de minimis exemption ended August 29, 2025, eliminating duty-free direct-from-Korea parcel shipping for cosmetic purchases under USD 800.
KORUS FTA preference does not produce a meaningfully lower rate than 15% on HTS 3304 finished cosmetic lines because most HTS 3304 subheadings sit at 0% MFN, and the 15% reciprocal applies on top.
At indie scale, the landed cost increase per unit is in the USD 0.55 to USD 0.75 range for typical serum and cream SKUs; gross margin compression is 2 to 4 points if fully absorbed.
The bigger founder problem is working capital timing, not the headline tariff number. Pre-launch landed inventory cash requirements rise ~14% for a typical 1,000-unit launch SKU.
Three response patterns dominate: selective US repackaging, dual-sourcing across origins, and price-plus-margin discipline. Most indie brands are using a blend.
The most movement in 2026 is on packaging cost lines, payment terms, and DDP versus FOB structure, not on the tariff rate itself.
FAQ
Does KORUS still give my K-beauty brand a tariff advantage? For finished cosmetic imports under HTS 3304, KORUS preference does not lower the duty meaningfully because the MFN rate is already 0% and the 15% reciprocal applies on top. KORUS still matters for some ingredient and packaging inputs, and for the country-of-origin audit trail. Document KORUS origin in your ODM contract regardless.
Can I ship under the de minimis rule if my parcel is under USD 800? No. The de minimis exemption ended August 29, 2025. Low-value parcels now face either the country-of-origin tariff rate (15% for Korea) or a fixed processing fee in the USD 80 to USD 200 range during the transition window.
Are Korean sunscreens subject to the 15% tariff? Sunscreens classified as OTC drugs in the US (HTS 3304.99 with sunscreen monograph drug claims, or other drug-classified HTS lines) are not Section 232 targets but the reciprocal tariff treatment depends on the specific HTS line. Most cosmetic-classified sunscreens (those marketed without OTC drug claims, more common in non-US markets) sit in HTS 3304 and face the 15% rate. We covered the related FDA regulatory question in our Korean sunscreen vs American sunscreen guide.
Should I switch to a US contract manufacturer to avoid the tariff? For most indie K-beauty brands, no. The Korean ODM advantages on formulation expertise, ingredient sourcing relationships, MOQ flexibility, and unit cost still typically outweigh the 15% tariff at indie scale. US contract manufacturer MOQs are often higher and unit costs on K-beauty-style formulations are typically USD 1.50 to USD 3.00 higher per unit. The math favors keeping production in Korea for most indie founders.
Will the 15% rate change? The November 2025 deal locked in the 15% cap. Future changes would require a new bilateral agreement or a unilateral US policy change. Indie founders should plan for the 15% to be stable through at least the medium term.
What is the impact on Korean ODM lead times? Lead times have lengthened modestly in the post-November 2025 window. Many Korean ODMs report a 1 to 3 week slowdown across the first half of 2026 as both they and their indie US clients reset purchase order commitments. Build a 2-week buffer into your launch timeline.
How do I check the exact HTS code and duty rate for my product? Ask your customs broker to file a binding ruling request with US Customs and Border Protection (CBP). The official source is the US International Trade Commission's Harmonized Tariff Schedule at hts.usitc.gov. For most K-beauty serums and creams, the HTS line is 3304.99.
Working With ALTA MEET
ALTA MEET is a Manhattan, NYC-based boutique consultancy that partners with indie US brands on the Korean ODM side: facility selection, cross-border negotiations, formulation briefs, MoCRA compliance, and the cost structure decisions that the post-tariff environment makes more consequential. We sit on the Korea side of the table so that founders can make decisions with full visibility into the manufacturer's actual constraints, not just the quote PDF.
If you want a quick gut-check on whether the tariff math, ODM negotiation strategy, or launch sequencing in your current K-beauty project is set up correctly for 2026, book a free 15-min K-Beauty manufacturing gut-check.
References
White House Fact Sheet, Joint Fact Sheet on President Donald J. Trump's Meeting with President Lee Jae Myung, November 13, 2025.
Office of the US Trade Representative, Fact Sheet: The United States and Korea Agree to the Korea Strategic Trade and Investment Deal, November 2025.
Federal Register, Implementing Certain Tariff-Related Elements of the U.S.-Korea Strategic Trade and Investment Deal, December 4, 2025.
US Customs and Border Protection, Korea Free Trade Agreement (KORUS) implementation guidance.
US International Trade Commission, Harmonized Tariff Schedule, Chapter 33, 2026 edition.
US Food and Drug Administration, Modernization of Cosmetics Regulation Act of 2022 (MoCRA), Responsible Person registration, facility listing, and adverse event reporting framework.
Standards cited: ISO 22716:2007 (Cosmetic GMP), ISO 17516:2014 (Microbiological limits), ICH Q1A(R2) (Stability testing), ICH Q1B (Photostability).
